X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-8-2023-82126.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204382
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204801
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-25-2023-68767.pdf
https://health.economictimes.indiatimes.com/news/pharma/zydus-lifesciences-gets-usfda-nod-for-generic-hypertension-drug/95374653
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215666
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-2-2022-77418.pdf
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/aurobindo-pharma-usa-inc-initiates-voluntary-nationwide-recall-two-2-lots-quinapril-and
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-17-2022-1660735823.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-13-2022-1649826529.pdf
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pfizer-voluntary-nationwide-recall-lots-accuretictm-quinapril-hclhydrochlorothiazide-quinapril-and
https://recalls-rappels.canada.ca/en/alert-recall/pfizer-recalls-accuretic-blood-pressure-tablets-due-nitrosamine-impurity
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-22-2021-1640158210.pdf
http://www.koreabiomed.com/news/articleView.html?idxno=12631
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-11-2021-1636538960.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215562
https://www.fda.gov/drugs/drug-safety-and-availability/fda-approves-label-changes-hydrochlorothiazide-describe-small-risk-non-melanoma-skin-cancer#:~:text=The%20increased%20risk%20of%20developing,squamous%20cell%20carcinoma%20(SCC).
https://www.fda.gov/drugs/drug-safety-and-availability/fda-approves-label-changes-hydrochlorothiazide-describe-small-risk-non-melanoma-skin-cancer#:~:text=%5B8%2F20%2F2020%5D,HCTZ%20use%20and%20to%20encourage
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212678
https://www.fiercepharma.com/pharma/astrazeneca-hawks-suite-hyptertension-drugs-for-350m-latest-asset-sale
https://www.fiercepharma.com/manufacturing/fda-warning-letter-tags-torrent-as-key-offender-production-tainted-blood-pressure
https://www.pharmacompass.com/pdf/news/torrent-pharmaceuticals-limited-expands-voluntary-nationwide-recall-of-losartan-potassium-tablets-1569033044.pdf
https://www.indiainfoline.com/article/news-top-story/glenmark-pharma-terms-report-on-stake-sale-to-premjiinvest-speculative-119082600070_1.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-recalls-products-from-us-market/articleshow/70826067.cms
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-21-2019-1566366765.pdf
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=6312019105346
https://www.bloomberg.com/news/articles/2019-06-18/fourth-carcinogen-discovered-in-heart-pills-used-by-millions
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-8-2019-1557294096.pdf
https://www.raps.org/news-and-articles/news-articles/2019/4/ema-urges-pioglitazone-manufacturers-to-check-for
https://www.pharmacompass.com/pdf/news/updated-torrent-pharmaceuticals-limited-expands-voluntary-nationwide-recall-of-losartan-potassium-tablets-1555650822.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-27-2019-1553661457.pdf
https://www.raps.org/news-and-articles/news-articles/2019/3/to-prevent-losartan-shortages-fda-allows-higher-i
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202544
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205769
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-teva-canadas-teva-losartan-hctz-50125mg-tablet-1552626132.pdf
https://www.pharmacompass.com/pdf/news/macleods-pharmaceuticals-issues-voluntary-nationwide-consumer-level-recall-of-one-lot-blm-715a-of-losartan-potassiumhydrochlorothiazide-combination-tablets-100mg25mg-1551155408.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208358
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209281
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-6-2019-1549474146.pdf
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/68976a-eng.php
https://www.fda.gov/Drugs/DrugSafety/ucm613916.htm?utm_campaign=UPDATE%20on%20angiotensin%20II%20receptor%20blocker%20%28ARB%29%20recalls%3A%20Torrent%20further%20expands&utm_medium=email&utm_source=Eloqua
https://www.fda.gov/downloads/Drugs/DrugSafety/UCM628993.pdf?utm_campaign=UPDATE%20on%20angiotensin%20II%20receptor%20blocker%20%28ARB%29%20recalls%3A%20Torrent%20further%20expands&utm_medium=email&utm_source=Eloqua
https://www.pharmacompass.com/pdf/news/torrent-pharmaceuticals-recalls-losartan-potassium-and-losartanhctz-tablets-1548327958.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-23-2019-1548227584.pdf
Market Place
Share 
